PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3. A total of 6 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,050,000 | -5.8% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,238,000 | +12.2% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,885,000 | -15.2% | 3,700,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $3,403,000 | +4.5% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,257,000 | +9.6% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,973,000 | -23.9% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,909,000 | +21.4% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,219,000 | -0.5% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,236,000 | -11.3% | 3,700,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,650,000 | +43.1% | 3,700,000 | +23.3% | 0.00% | 0.0% |
| Q3 2017 | $2,550,000 | +12.6% | 3,000,000 | +50.0% | 0.00% | 0.0% |
| Q2 2017 | $2,264,000 | -28.8% | 2,000,000 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $3,178,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,665,000 | $15,276,000 | 0.31% |
| ANGELO GORDON & CO., L.P. | 2,879,000 | $2,482,000 | 0.16% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 8,000,000 | $7,200,000,000 | 0.14% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,742,000 | $1,509,000 | 0.02% |
| CITIGROUP INC | 7,982,000 | $6,883,000 | 0.01% |
| Citadel Advisors | 3,700,000 | $3,219,000 | 0.00% |